Abstract
Purpose
The objective of this study was to investigate combinations of two chemopreventive dietary factors: EGCG 20 μM (or 100 μM) and SFN (25 μM) in HT-29 AP-1 human colon carcinoma cells.
Methods
After exposure of HT-29 AP-1 cells to SFN and EGCG, individually or in combination, we performed AP-1 luciferase reporter assays, cell viability assays, isobologram analyses, senescence staining, quantitative real-time PCR (qRT-PCR) assays, Western blotting, and assays for HDAC activity and hydrogen peroxide. In some experiments, we exposed cells to superoxide dismutase (SOD) or Trichostatin A (TSA) in addition to the treatment with dietary factors.
Results
The combinations of SFN and EGCG dramatically enhanced transcriptional activation of AP-1 reporter in HT-29 cells (46-fold with 25 μM SFN and 20 μM EGCG; and 175-fold with 25 μM SFN and 100 μM EGCG). Isobologram analysis showed synergistic activation for the combinations with combination index, CI < 1. Interestingly, co-treatment with 20units/ml of SOD, a free radical scavenger, attenuated the synergism elicited by the combinations (2-fold with 25 μM SFN and 20 μM EGCG; and 15-fold with 25 μM SFN and 100 μM EGCG). Cell viability assays showed that the low-dose combination decreased cell viability to 70% whereas the high-dose combination decreased cell viability to 40% at 48 h, with no significant change in cell viability at 24 h as compared to control cells. In addition, 20 μM and 100 μM EGCG, but not 25 μM SFN, showed induction of senescence in the HT-29 AP-1 cells subjected to senescence staining. However, both low- and high-dose combinations of SFN and EGCG attenuated the cellular senescence induced by EGCG alone. There was no significant change in the protein levels of phosphorylated forms of ERK, JNK, p38, and Akt-Ser473 or Akt-Thr308. Besides, qRT-PCR assays corroborated the induction of the luciferase gene seen with the combinations in the reporter assay. Relative expression levels of transcripts of many other genes known to be either under the control of the AP-1 promoter or involved in cell cycle regulation or cellular influx–efflux such as cyclin D1, cMyc, ATF-2, Elk-1, SRF, CREB5, SLCO1B3, MRP1, MRP2 and MRP3 were also quantified by qRT-PCR in the presence and absence of SOD at both 6 and 10 h. In addition, pre-treatment with 100 ng/ml TSA, a potent HDAC inhibitor, potentiated (88-fold) the synergism seen with the low-dose combination on the AP-1 reporter transcriptional activation. Cytoplasmic and nuclear fractions of treated cells were tested for HDAC activity at 2 and 12 h both in the presence and absence of TSA, however, there was no significant change in their HDAC activity. In addition, the H2O2 produced in the cell system was about 2 μM for the low-dose combination which was scavenged to about 1 μM in the presence of SOD.
Conclusion
Taken together, the synergistic activation of AP-1 by the combination of SFN and EGCG that was potentiated by HDAC inhibitor TSA and attenuated by free radical scavenger SOD point to a possible multifactorial control of colon carcinoma that may involve a role for HDACs, inhibition of cellular senescence, and SOD signaling.
Similar content being viewed by others
Abbreviations
- AP-1:
-
activator protein
- EGCG:
-
(−) epigallocatechin-3-gallate
- HDAC:
-
histone deacetylase
- MAPK:
-
mitogen-activated protein kinase
- qRT-PCR:
-
quantitative real-time PCR
- SFN:
-
sulforaphane
- SOD:
-
superoxide dismutase
- TSA:
-
Trichostatin A
References
Centers for disease control and prevention (CDC). Department of Health and Human Services. Available at http://www.cdc.gov/cancer/colorectal/statistics/death_rates.htm.
National Cancer Institute (NCI). Surveillance epidemiology and end results (SEER). Available at http://www.seer.cancer.gov/statfacts/html/colorect.html?statfacts_page=colorect.html&x=14&y=23.
M. D. Johnston, C. M. Edwards, W. F. Bodmer, P. K. Maini, and S. J. Chapman. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. USA 104:4008–4013 (2007).
I. P. Tomlinsonand, and W. F. Bodmer. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc. Natl. Acad. Sci. USA 92:11130–11134 (1995).
B. Vogelsteinand, and K. W. Kinzler. Cancer genes and the pathways they control. Nat. Med. 10:789–799 (2004).
M. D. Castellone, H. Teramoto, and J. S. Gutkind. Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection. Cancer Res. 66:11085–11088 (2006).
K. A. Steinmetzand, and J. D. Potter. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325–357 (1991).
K. A. Steinmetzand, and J. D. Potter. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2:427–442 (1991).
S. A. Smith-Warner, P. J. Elmer, L. Fosdick, B. Randall, R. M. Bostick, G. Grandits, P. Grambsch, T. A. Louis, J. R. Wood, and J. D. Potter. Fruits, vegetables, and adenomatous polyps: the Minnesota cancer prevention research unit case-control study. Am. J. Epidemiol. 155:1104–1113 (2002).
O. Leoni, R. Iori, and S. Palmieri. Hydrolysis of glucosinolates using nylon-immobilized myrosinase to produce pure bioactive molecules. Biotechnol. Bioeng. 68:660–664 (2000).
S. M. Getahunand, and F. L. Chung. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomark. Prev. 8:447–451 (1999).
M. C. Myzak, P. A. Karplus, F. L. Chung, and R. H. Dashwood. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 64:5767–5774 (2004).
J. V. Higdon, B. Delage, D. E. Williams, and R. H. Dashwood. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 55:224–236 (2007).
Y. S. Keum, S. Yu, P. P. Chang, X. Yuan, J. H. Kim, C. Xu, J. Han, A. Agarwal, and A. N. Kong. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma hepG2 cells. Cancer Res. 66:8804–8813 (2006).
H. Mukhtarand, and N. Ahmad. Mechanism of cancer chemopreventive activity of green Tea. Proc. Soc. Exp. Biol. Med. 220:234–238 (1999).
T. Yamane, H. Nakatani, N. Kikuoka, H. Matsumoto, Y. Iwata, Y. Kitao, K. Oya, and T. Takahashi. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 77:1662–1667 (1996).
X. Jiaand, and C. Han. Effects of green tea on colonic aberrant crypt foci and proliferative indexes in rats. Nutr. Cancer 39:239–243 (2001).
D. M. Noonan, R. Benelli, and A. Albini. Angiogenesis and cancer prevention: a vision. Recent Results Cancer Res. 174:219–224 (2007).
C. Chen, G. Shen, V. Hebbar, R. Hu, E. D. Owuor, and A. N. Kong. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24:1369–1378 (2003).
M. Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C. S. Yang. Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63:7563–7570 (2003).
M. Fang, D. Chen, and C. S. Yang. Dietary polyphenols may affect DNA methylation. J. Nutr. 137:223S–228S (2007).
S. Nair, W. Li, and A. N. Kong. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol. Sin. 28:459–472 (2007).
D. Barford. The role of cysteine residues as redox-sensitive regulatory switches. Curr. Opin. Struct. Biol. 14:679–686 (2004).
J. M. Hansen, W. H. Watson, and D. P. Jones. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82:308–317 (2004).
M. Karin. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483–16486 (1995).
T. Smeal, B. Binetruy, D. Mercola, A. Grover-Bardwick, G. Heidecker, U. R. Rapp, and M. Karin. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell Biol. 12:3507–3513 (1992).
C. Abate, L. Patel, F. J. Rauscher, 3rd, and T. Curran. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157–1161 (1990).
J. M. Hansen, Y. M. Go, and D. P. Jones. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu. Rev. Pharmacol. Toxicol. 46:215–234 (2006).
L. Zhao, M. G. Wientjes, and J. L. Au. Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin. Cancer Res. 10:7994–8004 (2004).
H. Seimiya, T. Oh-hara, T. Suzuki, I. Naasani, T. Shimazaki, K. Tsuchiya, and T. Tsuruo. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol. Cancer Ther. 1:657–665 (2002).
N. Arber, and B. Levin. Chemoprevention of colorectal cancer: ready for routine use? Recent Results Cancer Res. 5:517–525 (2005).
G. Rennert. Prevention and early detection of colorectal cancer—new horizons. Recent Results Cancer Res. 174:179–187 (2007).
B. Escudier, N. Lassau, E. Angevin, J. C. Soria, L. Chami, M. Lamuraglia, E. Zafarana, V. Landreau, B. Schwartz, E. Brendel, J. P. Armand, and C. Robert. Phase I Trial of Sorafenib in Combination with IFN {alpha}-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma. Clin. Cancer Res. 13:1801–1809 (2007).
C. Kudo-Saito, E. K. Wansley, M. E. Gruys, R. Wiltrout, J. Schlom, and J. W. Hodge. Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2. Clin. Cancer Res. 13:1936–1946 (2007).
V. M. Adhami, A. Malik, N. Zaman, S. Sarfaraz, I. A. Siddiqui, D. N. Syed, F. Afaq, F. S. Pasha, M. Saleem, and H. Mukhtar. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 13:1611–1619 (2007).
C. Chenand, and A. N. Kong. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol. Sci. 26:318–326 (2005).
C. Chenand, and A. N. Kong. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic. Biol. Med. 36:1505–1516 (2004).
C. Xu, M. T. Huang, G. Shen, X. Yuan, W. Lin, T. O. Khor, A. H. Conney, and A. N. Tony Kong. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 66:8293–8296 (2006).
R. Hu, T. O. Khor, G. Shen, W. S. Jeong, V. Hebbar, C. Chen, C. Xu, B. Reddy, K. Chada, and A. N. Kong. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis 27:2038–2046 (2006).
L. Bakiri, K. Matsuo, M. Wisniewska, E. F. Wagner, and M. Yaniv. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell Biol. 22:4952–4964 (2002).
J. Hess, P. Angel, and M. Schorpp-Kistner. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117:5965–5973 (2004).
G. D. Maurer, J. H. Leupold, D. M. Schewe, T. Biller, R. E. Kates, H. M. Hornung, U. Lau-Werner, S. Post, and H. Allgayer. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. Clin. Cancer Res. 13:1123–1132 (2007).
G. Shen, C. Xu, C. Chen, V. Hebbar, and A. N. Kong. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol. 57:317–327 (2006).
T. Herdegenand, and J. D. Leah. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28:370–490 (1998).
C. S. Hilland, and R. Treisman. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199–211 (1995).
B. Hagenbuchand, and P. J. Meier. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 447:653–665 (2004).
M. R. Ballestero, M. J. Monte, O. Briz, F. Jimenez, F. Gonzalez-San Martin, and J. J. Marin. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps. Biochem. Pharmacol. 72:729–738 (2006).
I. B. Roninson. Tumor cell senescence in cancer treatment. Cancer Res. 63:2705–2715 (2003).
J. A. Yaglom, V. L. Gabai, and M. Y. Sherman. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res. 67:2373–2381 (2007).
C. A. Schmitt, J. S. Fridman, M. Yang, S. Lee, E. Baranov, R. M. Hoffman, and S. W. Lowe. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335–346 (2002).
T. O. Khor, R. Hu, G. Shen, W. S. Jeong, V. Hebbar, C. Chen, C. Xu, S. Nair, B. Reddy, K. Chada, and A. N. Kong. Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharm. Drug Dispos. 27:407–420 (2006).
R. Hu, V. Hebbar, B. R. Kim, C. Chen, B. Winnik, B. Buckley, P. Soteropoulos, P. Tolias, R. P. Hart, and A. N. Kong. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther. 310:263–271 (2004).
B. R. Kim, R. Hu, Y. S. Keum, V. Hebbar, G. Shen, S. S. Nair, and A. N. Kong. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 63:7520–7525 (2003).
J. D. Lambert, M. J. Lee, L. Diamond, J. Ju, J. Hong, M. Bose, H. L. Newmark, and C. S. Yang. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 34:8–11 (2006).
J. D. Lambertand, and C. S. Yang. Mechanisms of cancer prevention by tea constituents. J. Nutr. 133:3262S–3267S (2003).
Acknowledgements
Sujit Nair is extremely grateful to Ms. Donna Wilson at the Keck Center for Collaborative Neuroscience, Rutgers University, for exhaustive training and extensive discussions that were very helpful in optimizing and validating the quantitative real-time PCR assays. This work was supported in part by RO1-CA073674 and RO1-CA092515 to Ah-Ng Tony Kong from the National Institutes of Health (NIH).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nair, S., Hebbar, V., Shen, G. et al. Synergistic Effects of a Combination of Dietary Factors Sulforaphane and (−) Epigallocatechin-3-gallate in HT-29 AP-1 Human Colon Carcinoma Cells. Pharm Res 25, 387–399 (2008). https://doi.org/10.1007/s11095-007-9364-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-007-9364-7